Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

SABCS 2011

11 Nov 2011
Renaissance Zurich Hotel, Zurich, Switzerland

Energy supply in cancer

Dr Michael Pollak - McGill Univeristy, Montreal, Canada
Energy supply in cancer ( Dr Michael Pollak - McGill Univeristy, Montreal, Canada )
20 Dec 2011

A new test to determine risk of recurrence in DCIS breast cancer

Dr Larry Solin - Albert Einstein Medical Center, Philadelphia, USA
A new test to determine risk of recurrence in DCIS breast cancer ( Dr Larry Solin - Albert Einstein Medical Center, Philadelphia, USA )
20 Dec 2011

A test to predict risk of recurrence in DCIS

Prof Joseph Sparano - Albert Einstein Cancer Center, New York, USA
A test to predict risk of recurrence in DCIS ( Prof Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
20 Dec 2011

Axillary dissection may be overtreatment in some breast cancer patients

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy
Axillary dissection may be overtreatment in some breast cancer patients ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )
20 Dec 2011

Clinical research within developing countries

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Clinical research within developing countries  ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
20 Dec 2011

Results from the GeparQuinto trial

Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland
Results from the GeparQuinto trial ( Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland )
20 Dec 2011

Analysis of the development of breast tissue

Prof Geoff Wahl – University of California, San Diego, USA
Analysis of the development of breast tissue ( Prof Geoff Wahl – University of California, San Diego, USA )
20 Dec 2011

Link between vitamin D levels and breast cancer

Dr Eitan Amir – Princess Margaret Hospital, Toronto, Canada
Link between vitamin D levels and breast cancer ( Dr Eitan Amir – Princess Margaret Hospital, Toronto, Canada )
20 Dec 2011

Biological differences in breast cancer cases due to age

Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA
Biological differences in breast cancer cases due to age ( Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA )
20 Dec 2011

The latest for advanced breast cancer

Dr Hope Rugo – University of San Francisco, California USA
The latest for advanced breast cancer ( Dr Hope Rugo – University of San Francisco, California USA )
20 Dec 2011

Long term effects oophorectomy, at a young age, on bone health

Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Long term effects oophorectomy, at a young age, on bone health ( Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA )
16 Dec 2011

Everolimus for postmenopausal women with advanced breast cancer

Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus for postmenopausal women with advanced breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011

Randomized Phase II Study in Patients with HER2-Positive Breast Cancer

Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer  ( Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy )
16 Dec 2011

Effects of breast reconstructive surgery after mastectomy

Dr Dawn Hershman - Columbia University Medical Center, New York, NY
Effects of breast reconstructive surgery after mastectomy ( Dr Dawn Hershman - Columbia University Medical Center, New York, NY )
16 Dec 2011

Influence of age and BRCA status on contralateral breast cancer risk

Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam
Influence of age and BRCA status on contralateral breast cancer risk ( Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam )
16 Dec 2011

Treatment of breast cancer as a chronic disease

Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA
Treatment of breast cancer as a chronic disease ( Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA )
16 Dec 2011

Genetic differences responsible for outcome in hormone receptor positive early stage breast cancer

Prof Minetta Liu - Georgetown University, Washington, USA
Genetic differences responsible for outcome in hormone receptor positive early stage breast cancer ( Prof Minetta Liu - Georgetown University, Washington, USA )
16 Dec 2011

Everolimus improved PFS in advanced hormone receptor positive breast cancer

Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus improved PFS in advanced hormone receptor positive breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011

Breast cancer, exercise and weight loss

Dr Jennifer Ligibel - Dana-Faber Cancer Institute, Boston, USA
Breast cancer, exercise and weight loss ( Dr Jennifer Ligibel - Dana-Faber Cancer Institute, Boston, USA )
16 Dec 2011

Bevacizumab improves PFS in HER-2-positive breast cancer

Prof Luca Gianni - Università Vita-Salute San Raffaele, Milan, Italy
Bevacizumab improves PFS in HER-2-positive breast cancer ( Prof Luca Gianni - Università Vita-Salute San Raffaele, Milan, Italy )
16 Dec 2011

Links between early life exposures and breast cancer

Prof Michele Forman - University of Texas, Austin, USA
Links between early life exposures and breast cancer ( Prof Michele Forman - University of Texas, Austin, USA )
16 Dec 2011

Use of neutrophils to prevent lung metastases in breast cancer patients

Dr Robert Benezra - Memorial Sloan-Kettering Cancer Center, New York, USA
Use of neutrophils to prevent lung metastases in breast cancer patients ( Dr Robert Benezra - Memorial Sloan-Kettering Cancer Center, New York, USA )
16 Dec 2011

CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel

Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel  ( Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA )
14 Dec 2011